<?xml version='1.0' encoding='UTF-8'?>
<PolymerNanocomposite><PDB_ID>1OHR</PDB_ID><DATA_SOURCE><Citation><CitationType>research article</CitationType><Publication>Journal of Medicinal Chemistry</Publication><Title>Viracept (Nelfinavir Mesylate, AG1343):&amp;#160; A Potent, Orally Bioavailable Inhibitor of HIV-1 Protease</Title><Author>Kaldor, Stephen W.</Author><Author>Kalish, Vincent J.</Author><Author>Davies, Jay F.</Author><Author>Shetty, Bhasker V.</Author><Author>Fritz, James E.</Author><Author>Appelt, Krzysztof</Author><Author>Burgess, Jeffrey A.</Author><Author>Campanale, Kristina M.</Author><Author>Chirgadze, Nickolay Y.</Author><Author>Clawson, David K.</Author><Author>Dressman, Bruce A.</Author><Author>Hatch, Steven D.</Author><Author>Khalil, Deborah A.</Author><Author>Kosa, Maha B.</Author><Author>Lubbehusen, Penny P.</Author><Author>Muesing, Mark A.</Author><Author>Patick, Amy K.</Author><Author>Reich, Siegfried H.</Author><Author>Su, Kenneth S.</Author><Author>Tatlock, John H.</Author><Publisher>American Chemical Society</Publisher><PublicationYear>1997</PublicationYear><DOI>10.1021/jm9704098</DOI><Volume>40</Volume><Issue>24</Issue></Citation></DATA_SOURCE><MATERIALS><Matrix><MatrixComponent><MacroMoleculeClass>ASPARTYL PROTEASE</MacroMoleculeClass><MacroMoleculeType>Protein</MacroMoleculeType><ManufacturerOrSourceName>Human immunodeficiency virus 1</ManufacturerOrSourceName><MolecularWeight><value>22175.29</value></MolecularWeight></MatrixComponent></Matrix></MATERIALS><CHARACTERIZATION><XRay_Diffraction_and_Scattering><Description>Resolution: 2.1</Description></XRay_Diffraction_and_Scattering></CHARACTERIZATION><PROPERTIES><Biological><Sequence>PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF</Sequence><SpaceGroup>P 21 21 21</SpaceGroup></Biological></PROPERTIES></PolymerNanocomposite>